Search Share Prices
GSK News - Hikma and Vectura make new application for GSK knock-off
The generics giant and the inhaled medicines specialist have developed VR315US, a knock-off version of GlaxoSmithKline PLC’s (LON:GSK) top-selling asthma treatment, Advair Diskus, which generated ...
UBS upgrades GSK as HIV business is set to grow rapidly
An injectable drug that launches in the US this year also might generate revenues of almost £700mln by 2023. There are risks over approval of two key oncology assets GlaxoSmithKline PLC (LON:GSK) was ...
Demand For Immune-Oncology Treatments To Reach A Market Value Of USD 157,230.48 Million On The Back Of Rising Cases Of Cancer By 2027
(lon:GSK). Request For Full Report @ https://www.researchnester.com/sample-request-2103 The profiling enfolds key information of the companies which encompasses business overview, products and ...
Need To Know: GlaxoSmithKline plc (LON:GSK) Insiders Have Been Selling Shares
So shareholders might well want to know whether insiders have been buying or selling shares in GlaxoSmithKline plc (LON:GSK). Most investors know that it is quite permissible for company leaders, such ...